ArticleMolecular biology reports2026
Genomic surveillance of SARS-CoV-2: a resource-efficient wastewater-based workflow.
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
backgroundSARS-CoV-2 has been deeply characterized. However, large-scale clinical sequencing remains unaffordable or is declining in many regions, threatening the detection of new viral variants. While clinical mutations can be identified by analyzing wastewater samples, the potential of this tool for diversity analyses remains underexploited. Additionally, current procedures for virus concentration and purification continue to undergo refinement. METHODS AND
resultsThis study presents a workflow integrating a high-purity laboratory procedure and an information theory-based R package to generate high-coverage, high-depth genomic data and to profile amino acid-level diversity. The workflow was validated using samples from a single urban node, successfully recovering known features of SARS-CoV-2 diversity at two contrasting stages of the COVID-19 pandemic: early regional endemism and late-stage Omicron cosmopolitanism. Clinically elusive mutations and single-nucleotide variants attributable to countrywide lineages were effectively identified in both early and late samples. The resulting analysis also revealed spatial distribution signatures consistent with the regional endemism typical of ancestral lineages and the global dissemination of Omicron subvariants. The workflow also allowed detecting location-specific mutation frequency differences, revealing biogeographical trends that may escape clinical surveillance. Finally, hotspots of high amino acid diversity were identified at receptor binding domain positions known to drive infectivity, transmissibility and immune escape.
conclusionsTogether, these results indicate that wastewater can support effective genomic monitoring. The workflow proposed provides an accessible complement to clinical surveillance, especially in settings where large-scale, patient-level sequencing is limited or unavailable.
Indexed as
Identifiers
42334739What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.